A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy Participants

Clinical trial NCT05984251 · COMPLETED

Trial details

NCT number: NCT05984251
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Vasculitis Systemic Lupus Erythematosus (SLE)

Start date: 2009-12-21
Primary completion: 2010-09-19
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.